- Home
- CTNM vs ERH Comparison
CTNM vs ERH Comparison
Compare CTNM & ERH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- ERH
- Stock Information
- Founded
- CTNM 2009
- ERH 2004
- Country
- CTNM United States
- ERH United States
- Employees
- CTNM N/A
- ERH N/A
- Industry
- CTNM
- ERH Finance/Investors Services
- Sector
- CTNM
- ERH Finance
- Exchange
- CTNM Nasdaq
- ERH Nasdaq
- Market Cap
- CTNM 114.1M
- ERH 97.6M
- IPO Year
- CTNM 2024
- ERH N/A
- Fundamental
- Price
- CTNM $3.51
- ERH $11.25
- Analyst Decision
- CTNM Strong Buy
- ERH
- Analyst Count
- CTNM 4
- ERH 0
- Target Price
- CTNM $23.75
- ERH N/A
- AVG Volume (30 Days)
- CTNM 83.1K
- ERH 23.2K
- Earning Date
- CTNM 05-14-2025
- ERH 01-01-0001
- Dividend Yield
- CTNM N/A
- ERH 8.85%
- EPS Growth
- CTNM N/A
- ERH N/A
- EPS
- CTNM N/A
- ERH N/A
- Revenue
- CTNM N/A
- ERH N/A
- Revenue This Year
- CTNM N/A
- ERH N/A
- Revenue Next Year
- CTNM N/A
- ERH N/A
- P/E Ratio
- CTNM N/A
- ERH N/A
- Revenue Growth
- CTNM N/A
- ERH N/A
- 52 Week Low
- CTNM $3.69
- ERH $7.97
- 52 Week High
- CTNM $22.00
- ERH $10.91
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- ERH 65.18
- Support Level
- CTNM N/A
- ERH $10.92
- Resistance Level
- CTNM N/A
- ERH $11.28
- Average True Range (ATR)
- CTNM 0.00
- ERH 0.18
- MACD
- CTNM 0.00
- ERH 0.03
- Stochastic Oscillator
- CTNM 0.00
- ERH 93.24
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About ERH Allspring Utilities and High Income Fund
Allspring Utilities and High Income Fund is a diversified closed-end management investment company. Its investment objective is to seek a high level of current income and moderate capital growth, with an emphasis on providing tax-advantaged dividend income. The company allocates a majority of its total assets to a sleeve that places a focus on common, preferred, and convertible preferred stocks of utility companies and the rest of its total assets to a sleeve of U.S. dollar denominated below investment grade (high yield) debt.